This inventor holds 2 USPTO granted patents, plus 1 CIPO patent and 1 EPO patent. Top assignees: Glaxosmithkline Intellectual Property Development Limited, University of Dundee. Active years: 2018-2019.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:


Years Active: 2018-2019
Title: Maria Marco Martin: Innovator in Antiparasitic Agents
Introduction
Maria Marco Martin is a distinguished inventor based in Madrid, Spain. She has made significant contributions to the field of medicinal chemistry, particularly in the development of antiparasitic agents. With a total of 2 patents, her work focuses on innovative compounds that address critical health challenges.
Latest Patents
Among her latest patents, Maria has developed compounds that include a compound of Formula (I) and imidazo[1,2-B][1,2,4]triazine derivatives. These compounds are designed as antiparasitic agents, with applications in treating diseases such as Chagas disease, Human African Trypanosomiasis (HAT), and leishmaniasis, particularly visceral leishmaniasis (VL). Her research emphasizes the therapeutic potential of these compounds, including their preparation processes and compositions.
Career Highlights
Maria has worked with notable organizations, including GlaxoSmithKline Intellectual Property Development Limited and the University of Dundee. Her career reflects a commitment to advancing medical science through innovative research and development.
Collaborations
Throughout her career, Maria has collaborated with esteemed colleagues, including Stephen Brand and Eun Jung Ko. These partnerships have further enriched her research and contributed to her success in the field.
Conclusion
Maria Marco Martin stands out as a leading inventor in the development of antiparasitic agents. Her innovative work and collaborations continue to make a significant impact in the field of medicinal chemistry.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile